Alnylam Pharmaceuticals: Promising Advancements in Alzheimer’s Treatment with RNA Interference Therapeutics
Analyst Patrick Trucchio of H.C. Wainwright reiterated a Buy rating on Alnylam Pharma (ALNY – Research Report), boosting the price target to ...
bovnews3h
Verrica Pharmaceuticals Inc (VRCA) Stock: Analyzing Its Quiet Power
On Wednesday, Verrica Pharmaceuticals Inc (VRCA) stock saw a modest uptick, ending the day at $1.24 which represents a slight increase of $0.13 or 11.71% from the prior close of $1.11. The stock ...
Crypto's Big Bang: Hut 8 Skyrocket by Over 150% as Trump's Bitcoin Plan Promises a New Era
Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/90.BMDkfsfZ.js ...
Hosted on MSN8h
Bitcoin Miner Iren Sees Target Hikes On Earnings; Bitcoin Rebounds Above $96k
Bitcoin miner Iren received price target hikes after reporting earnings, 28% spike in AI revenue. Bitcoin price rebounds ...
MediWound price target lowered to $25 from $28 at H.C. Wainwright
H.C. Wainwright analyst Swayampakula Ramakanth lowered the firm’s price target on MediWound (MDWD) to $25 from $28 and keeps a Buy rating on ...
bovnews22h
H.C. Wainwright Just Downgraded Eyenovia Inc (EYEN) Stock—What Does This Mean for Investors?
H.C. Wainwright has recently reduced Eyenovia Inc (EYEN) stock to Neutral rating, as announced on November 18, 2024, according to Finviz. Earlier, on March 1, 2021, Northland Capital had initiated the ...